GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Archived. This submission is more than a year old. Votes and new comments are closed, and some of the advice in it may have been superseded — check the community wiki for the current version.
7.7k
c/tirzepatide·posted 1 year ago by u/blunt_coldbox29

[Meta] proposal — a flair for SURMOUNT posts

Results Well Actually ×1 Slow Clap ×2 Cold Box ×3

proposal — a flair for SURMOUNT posts. Nothing about this affects the ranking maths, before anyone asks.

Switching from semaglutide, since three people asked in this thread alone.

There is no published dose equivalence between the two. The conversion tables that circulate are somebody’s arithmetic, not data. What people report here is that the first month after a switch is often flat, that the appetite effect feels differently shaped rather than simply stronger, and that starting at the bottom of the ladder again is the common approach.

None of that is a recommendation. It is what the threads say, and the threads are not a clinic.

Week 37 was the first time the scale moved after a five-week stall. I changed nothing in that window.

The thing nobody warned me about was how much of this is logistics — storing it, remembering it, the same day every week.

Corrections welcome, especially the pedantic ones. Pedantry is how this board earns its reputation.

8,282 up / 540 down94% upvoted26 commentsid rqw9z825 May 2025

26 comments

11 in this archive, depth 6

best — the order this archive was captured in

u/kofi_balogun875 points·1 year ago

The distribution matters more than the mean. In the trial population the interquartile spread was wide enough that two honest people can have completely different runs on the same arm.

replysharereportpermalink
u/noor_hovland546 points·1 year ago

Went 10 to 12.5 on the calendar and had the worst fortnight of the whole run. Dropped back to 10 and everything settled.

replysharereportpermalink
u/vito_chowdhury590 points·1 year ago

28kg over 59 weeks, never went past 10mg, and sulphur burps stayed mild the whole way. Posting because the loud threads are all 15mg.

replysharereportpermalink
u/dario_vermeulen0 points·1 year ago

The four-week interval in the label is a minimum. Nothing about the pharmacology requires you to step on schedule, and the trials stepped on a calendar because trials have to.

replysharereportpermalink
u/zeynep_ndiaye1 point·1 year ago

Right. And the sema-to-tirz "conversion" people post is invented. There is no published equivalence.

replysharereportpermalink
u/ahmed_fonseca485 points·1 year ago

28kg over 59 weeks, never went past 10mg, and sulphur burps stayed mild the whole way.

This. The step interval is a floor, and reading it as a timetable is the most expensive mistake in the thread.

replysharereportpermalink
u/teodor_szabo368 points·1 year ago

SURMOUNT-1 landed around 21% at 72 weeks on the top arm

replysharereportpermalink
u/slow_logbook_ftw176 points·1 year ago

SURMOUNT-1 landed around 21% at 72 weeks on the top arm

teodor_szabo is right that the two molecules are not interchangeable. There is no published conversion and the ones circulating are invented.

replysharereportpermalink
u/piotr_nascimento63 points·1 year ago

teodor_szabo is right that the two molecules are not interchangeable.

Agreed, with one qualifier: that is the mean of the top arm and the spread around it was enormous.

replysharereportpermalink
u/zaid_balogun257 points·1 year ago

Appetite effect for me is flat across seven days. On sema it was a wave. Same person, different molecule.

replysharereportpermalink
u/throwaway_wl2026191 points·1 year ago

Appetite effect for me is flat across seven days.

Not sure about this bit. The GIP arm being real does not tell you that it is what caused your particular week.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/tirzepatide

Tirzepatide-specific discussion: the dual-agonist pharmacology, the 2.5 → 15mg ladder, the appetite profile people describe as different from semaglutide, and the SURMOUNT/SURPASS trial programme. Comparisons with semaglutide are welcome as long as they are specific about dose equivalence being unknown.

187kmembers
130submissions
Aug 2023created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/tirzepatide rules
  1. "Tirz is better than sema" needs a comparator dose or it is a vibe, not a claim.
  2. Vial-splitting and self-compounding discussion stays in c/reconstitution.
  3. No pen-cracking tutorials. Discussing that people do it is fine; instructions are not.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.